HN Explorer

Ask HN: What would you think of no-IP pharma?

2 points by dnautics ↗ HN
What would you guys think about a potential pharmaceutical agent released with explicit anti-IP protections? I.E. that no pharma company would be able to exercise patenting rights on its use. I'm in a position to influence this to happen, obviously I think this is a good idea. Pros? Cons? Do any copyleft/no-ip folks know if this has been tried before? A cursory search says no, which doesn't suprise me considering how enthralled to the system many of my colleagues are.

2 comments

[ 2.9 ms ] story [ 19.3 ms ] thread
Daniel_Newby
It costs $1M+ for a basic obviously-no-safety-risks safety approval. A large market blockbuster drug can easily cost $100M to approve.

So no IP = drug vanishes without a trace. Unless you can get charitable funding for approval, like the Gates Foundation is doing for things like malaria.

dnautics
it's cheaper for anti-cancer drugs. Generic drug companies make way more than $100M in profits.